Related references
Note: Only part of the references are listed.NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Christina I. Tsien et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Re-irradiation for recurrent high grade glioma (HGG) patients: Results of a single arm prospective phase 2 study
Pierina Navarria et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
Fabiana Gregucci et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Brain Linac-Based Radiation Therapy: Test Drive of New Immobilization Solution and Surface Guided Radiation Therapy
Fabiana Gregucci et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
Fabiana Gregucci et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
High-dose re-irradiation of intracranial lesions - Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculation
I Stiefel et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)
Volume de-escalation in radiation therapy: state of the art and new perspectives
Bruno Meduri et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option
Gokhan Yaprak et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2020)
Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
Rosario Mazzola et al.
FRONTIERS IN ONCOLOGY (2019)
Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept
E. Braeutigam et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc) for Linac-based VMAT radiosurgery in brain metastases
Filippo Alongi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)
Pierina Navarria et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
Giuseppe Lombardi et al.
LANCET ONCOLOGY (2019)
Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era
Michael J. Gigliotti et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2018)
SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017)
M. Martinez-Garcia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy
Douglas E. Holt et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
Gamma Knife Radiosurgery in Recurrent Glioblastoma
Josa M. Frischer et al.
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY (2016)
CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations
Alfredo Conti et al.
SPRINGERPLUS (2015)
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models
Estelle Daudigeos-Dubus et al.
PLOS ONE (2015)
Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
Maya Flieger et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Hypofractionated stereotactic reirradiation for recurrent glioblastoma
Gozde Yazici et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study
Kyung-Jae Park et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article
Orin Bloch et al.
JOURNAL OF NEUROSURGERY (2012)
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study
Mario Balducci et al.
NEURO-ONCOLOGY (2012)
Gamma Knife Surgery versus Reoperation for Recurrent Glioblastoma Multiforme
Bente Sandvei Skeie et al.
WORLD NEUROSURGERY (2012)
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Re-irradiation with Radiosurgery for Recurrent Glioblastoma Multiforme
J. A. Torok et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2011)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
SAFETY AND EFFICACY OF BEVACIZUMAB WITH HYPOFRACTIONATED STEREOTACTIC IRRADIATION FOR RECURRENT MALIGNANT GLIOMAS
Philip H. Gutin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival
Mehul Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Stereotactic radiosurgery for glioblastoma: retrospective analysis
Tithi Biswas et al.
RADIATION ONCOLOGY (2009)
Hypofractionated stereotactic re-irradiation:: Treatment option in recurrent malignant glioma -: art. no. 55
D Vordermark et al.
BMC CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Salvage therapy in patients with glioblastoma -: Is there any benefit?
P Hau et al.
CANCER (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)